<DOC>
	<DOCNO>NCT02373891</DOCNO>
	<brief_summary>Acebrophylline metabolize separated Ambroxol 7-theophylline orally administer salt compose acid-base compound synthesize chloride ( salifying ) ambroxol 7-theophylline . Acebrophylline selectively apply bronchial lung tissue inhibit activity phospholipase bronchoalveolar show expectorant action raise surface activity alveolar , leukotrienes ( LTs ) suppress production prostaglandin ( PGs ) , show potent anti-inflammatory activity , bronchial celebrate reduce bronchial hyperreactivity normal state allow recuperate extend . It develop improve compliance improve pharmaceutically Acebrophylline intake twice daily 100mg Surfolase CR intake daily 200mg</brief_summary>
	<brief_title>Study Evaluate Effect Food Pharmacokinetics Surfolase CR Tablet Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male subject age 20 55 year , BMI &gt; 18.5 , &lt; 25 , inclusive *Body mass index ( kg/m2 ) = weight ( kg ) / ( height ( ) 2 ) 2 . Subject n't congenital chronic disease abnormal medical examination result . 3 . Subject healthy ( clinically relevant finding investigation preexamination ) judge investigator Hematology test : WBC differential count , RBC , Hemoglobin , Hematocrit , Platelet , PT ( INR ) /aPTT Blood chemistry test : Calcium , Inorganic Phosphate , Fasting Glucose , BUN , Creatinine , Cholesterol , Total Protein , Albumin , Total Bilirubin , Alkaline phosphatase , AST , ALT , rGT , LDH , TG , K , Na , Cl , uric acid , CPK Immune serum test : HBsAg , antiHCV Ab , antiHIV Ag/Ab , βhCG Urinalysis : Specific Gravity , pH , Protein , Glucose , Ketone , RBC , Urobilinogen , Bilirubin , Nitrite , WBC , Color , Turbidity , Sediment , Microscopy Urine drug screen test : Amphetamine , Barbiturate , Morphine , Benzodiazepine , Cocaine 4 ) If woman , must negative pregnancy test screening . Postmenopausal ( period least two year ) Surgical sterilization ( Hysterectomy bilateral oophorectomy , tubal ligation ) Before screening , interfile male partner man sole partner person Before Investigational product first dose administer least 14 day start appropriate contraception least 28 day . 5 ) If male sexually active woman childbearing age , trial period contraception ( condom , etc . ) clinical trial duration , IND maintain adequate contraception 28 day last dose , one party must agree donate sperm 6 ) Subjects sign date informed consent form indicate subject decide participate study inform pertinent aspect study 1 . Subject know hypersensitivity reaction acebrophylline , xanthine food . 2 . Patients genetic problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption 3 . Subject serious active cardiovascular , respiratory , hepatologic , renal , hematologic , gastrointestinal , immunologic , dermal , neurologic , psychological disease history disease 4 . Subject known history gastrointestinal disease gastrointestinal surgery affect absorption drug 5 . Subjects follow condition screen ( blood pressure , 12lead ECG , blood , urinalysis , etc . ) 6 . Subject follow condition laboratory test AST ALT &gt; Upper normal limit × 1.25 Total bilirubin &gt; Upper normal limit × 1.5 7 . If estimate GFR &lt; 80mL/min/1.73m2 use MDRD formula . ※ MDRD equation ( mL/min/1.73m2 ) : GFR = 175 x Scr1.154 x age0.203 8 . Systolic blood pressure &lt; =90mmHg diastolic blood pressure &gt; =150mmHg person show corresponding figure &lt; =50mmHg &gt; =100mmHg vital sign . 9. Who history drug abuse ( especially hypnotic , central act analgesic , psychotropic drug , opiates central nervous system act drug ) show positive reaction drug abuse urine drug screening test . 10 . Excessive caffeine alcohol intake , smoke person ( caffeine : &gt; 5cups/day , alcohol : &gt; 210g/week , tobacco : &gt; 10 cagarettes/day ) 11 . Person nonsmoking , nonalcohol hospital stay . 12 . Use prescription medication within 14 day prior study medication dosing use medication overthecounter medication include oriental medication within 7 day prior study medication dose 13 . Participation clinical investigation within 60days prior study medication dose 14 . Subjects whole blood donation within 60days , component blood donation within 30days 15 . Women pregnant breastfeed 16 . Person eat , include highfat diet ( 900kcal , contain 35 % fat ) serve trial period 17 . Person prohibit consumption grapefruitcontaining food trial period . 18 . Subjects decision nonparticipation investigator 's review due laboratory test result excuse nonresponding request instruction investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>